Metabolites derived from any human flavin-containing monooxygenase (FMO) subtype can now be produced as a service offering at Hypha. Recombinant… read more →
Great to see Hypha recognised for producing a glucuronide metabolite of praliciguat (M3) in the paper just out in the… read more →
We illustrate application of our one-stop metabolite shop in meeting metabolite requirements for various client projects using different techniques in… read more →
Hypha remain fully operational and are monitoring the COVID-19 situation closely. We have implemented a number of measures in response… read more →
Some metabolites are not easy to access. Even if sufficient material can be isolated from biological matrices for definitive metID,… read more →
As a leading specialist CRO for drug metabolite provision, Hypha has formed a partnership with Cypex Limited, experts in the… read more →
Our latest PolyCYPs bulletin features a case study in which one of our US pharma clients needed rapid access to… read more →
We are excited to announce the official launch of our One-Stop Metabolite Shop, which offers a complete solution for pharma… read more →
WEBINARS – 5th & 10th December If you missed the recent webinars on Hypha’s new “One-stop metabolite shop” featuring our… read more →
Hypha are pleased to announce the launch of their One-Stop Metabolite Production Service, strengthening Hypha’s reputation as a go-to company… read more →